Clinical trialEarly phase 1
UDP-003 (Cyclarity), 7-ketocholesterol clearance
NCT06813339
Early Phase 1, 84 участника по плану; SAD/MAD у здоровых добровольцев и открытая когорта до 9 пациентов.
No news refers to this card yet.
Also in the catalogue
- PURIFY-TIMI 81 (YN001)Clinical trial
- YN001 + evolocumab (Australia)Clinical trial
- YN001 liposomal rosuvastatin (Beijing Inno Medicine)Clinical trial
- CTX310 Phase 1b (secondary identifier NCT07491172)Clinical trial
- VERVE-102 Heart-2Clinical trial
- Long-term follow-up of gene-editing recipients (up to 15 years)Clinical trial
Scales
Identifiers
- NCT
- NCT06813339
Original sources
Details
- Phase
- Early phase 1
- Status
- Recruiting
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.